Aelis Farma SA

€1.02As of Sun 8 Nov 2026, 12:00 UTC
EPA:AELISHealthcare
Country France
PE (Fwd) •••
TSR 5Y CAGR (42.13%)
Div yield —
ROE (112.53%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (11.30%)
Mkt cap €13.87M
ROIC (276.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€1.28
25.86%
(8.62%)
Hold 7|12|5|4|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.02
0.03
0.03
0.03
28.11%
36.99%
28.92%
36.13%
Revenue€M
1.105
1.146
1.146
1.146
1.90%
5.71%
2.22%
2.01%
Peers (US$15.57M)
Cap (US$)
PE
16.67M
—
15.57M
—
Capital
TTM
5Y
10Y
Leveragex
0.303
0.400
0.327
EBIT/Intx
0.892
0.287
0.270
Own earn%
(15.16)
246.95
197.47
Sh yield%
23.13
37.12
41.07
Owners
Insiders/Inst%
11.34
50.58
Short interest%
1.86
SBC / revenue%
1.28
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
23–31
$1 testx
—
Incr. ROIC%
7